(2-Chloro-5-(ethoxycarbonyl)phenyl)boronic acid, 95.0%, 25g

2,7-Difluoro-9H-fluoren-9-one, 98%, 1g

3,5-Dichloro-4-nitropyridine, 95.0%, 10g

5-Bromothiophene-2-sulfonamide, 97.0%, 25g

(2R,3R,4R,5R)-5-(4-benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-yl benzoate, 97%, 10g

Tétraoxaundécane, SOLVAGREEN® min.99%, pour la synthèse, 500 ml, conditionnement en verre

2-(5-Chloro-2-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 250mg

(S)-3,3'-Bis([1,1'-biphenyl]-4-yl)-[1,1'-binaphthalene]-2,2'-diol, 5g

2-Fluoro-5-methylphenyl isothiocyanate, 1g

3-(5-Amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-2,6-piperidinedione, 97%, 100mg

2-Fluoro-4-formylbenzoic acid, 95.0%, 100mg

Solution étalon ICP de magnésium, 500 ml, 10 000 mg/l Mg, HDPE

Methyl 4-bromo-5-cyanothiophene-2-carboxylate, 95+%, 250mg